pd 98059 has been researched along with Chronic Kidney Diseases in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, S | 1 |
| Ning, X | 1 |
| Zhai, Y | 1 |
| Du, R | 1 |
| Lu, Y | 1 |
| He, L | 1 |
| Li, R | 1 |
| Wu, W | 1 |
| Sun, W | 1 |
| Wang, H | 1 |
1 other study available for pd 98059 and Chronic Kidney Diseases
| Article | Year |
|---|---|
Egr-1 mediates chronic hypoxia-induced renal interstitial fibrosis via the PKC/ERK pathway.
Topics: Animals; Cadherins; Calcium-Binding Proteins; Cell Hypoxia; Cells, Cultured; Early Growth Response P | 2014 |